Skip to content
CNS Clinical Research

Research area

Multiple Sclerosis (MS) clinical trials

Relapsing and progressive forms of MS are the focus of multiple sclerosis studies, which test investigational medications and rehabilitation approaches. To find out whether a study may fit you or someone you care for, start with CNS Clinical Research.

Updated

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Multiple sclerosis studies in numbers

multiple sclerosis studies recruiting in the U.S.
159
states with a study site
41
studies that accept healthy volunteers
38

Source: ClinicalTrials.gov. Data processed .

Find multiple sclerosis studies by state

These states have the most studies recruiting right now.

Multiple sclerosis studies recruiting now

As of November 16, 2026, 159 multiple sclerosis studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications62
  • other approaches29
  • behavioral approaches such as talk therapy or training24
  • devices20
  • biologics such as vaccines or antibodies12

A study can test more than one.

Main purpose

  • treating a condition81
  • diagnosis10
  • supportive care9
  • basic science4

Phase

  • Early Phase 14
  • Phase 114
  • Phase 1/28
  • Phase 216
  • Phase 2/31
  • Phase 310
  • Phase 47
  • No phase52
  • Observational47

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other104
  • industry40
  • government15

Who they enroll

  • adults (18 to 64)157
  • older adults (65 and over)128
  • children (under 18)19

38 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 159 studies.

Recently updated multiple sclerosis studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

    • Observational
    • From 1 month, up to 99 years
    • All sexes
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting in
    Bethesda, MD
    Registry record
    NCT00794352 · updated
  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Baltimore, MD · Bethesda, MD · Boston, MA · and 28 more U.S. locations
    Registry record
    NCT03816345 · updated
  3. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Albuquerque, NM · Boca Raton, FL · Bradenton, FL · and 22 more U.S. locations
    Registry record
    NCT07299019 · updated
  4. Skeletal Muscle Aging and Responsiveness in Aged People With MS

    • No phase
    • Ages 60 and older
    • All sexes
    Sponsor
    Oklahoma Medical Research Foundation
    Recruiting in
    Oklahoma City, OK
    Registry record
    NCT07500727 · updated
  5. Evaluation of an Online, On Demand Multimodal Wellness Program to Reduce Fatigue and Improve Quality of Life in Progressive Multiple Sclerosis.

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    University of Iowa
    Recruiting in
    Iowa City, IA
    Registry record
    NCT07831928 · updated
  6. Kesimpta (Ofatumumab) Pregnancy Registry

    • Observational
    • Ages 18 to 100
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    La Jolla, CA
    Registry record
    NCT05634967 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in the United States on ClinicalTrials.gov.

What multiple sclerosis studies look at

For both relapsing and progressive forms of MS, multiple sclerosis studies examine investigational medications and rehabilitation approaches. Because each study is built around one specific question, what you are asked to do will vary from one study to the next.

Whatever a study is testing is investigational. Researchers do not yet know how well it works or what its risks are. That is why the study exists.

Who may be able to take part

Each MS study sets requirements of its own. A study may look at how old you are, your past health, the medications you take now, and the way the condition affects you. People without the condition are also enrolled in certain studies.

Eligibility is not something you have to figure out alone. At a screening visit, the study team does that check for you. Learn what happens during eligibility and screening.

What taking part usually involves

  1. A first conversation

    Before anything else happens, a coordinator walks you through the study in general terms and answers the questions you have.

  2. Informed consent

    Before you agree to anything in an MS study, the team running it hands you a written document that covers every detail, including the risks already known. Whether to agree is your decision.

  3. Screening

    Screening for an MS study means answering health questions and having tests, and the results show if the study is a suitable fit for you. Screening does not always lead to taking part.

  4. Study visits

    Joining an MS study means attending visits on a set schedule, which is how the team keeps track of your health. You are free to stop taking part whenever you choose.

Questions about multiple sclerosis studies

Do I need a diagnosis to join a study about multiple sclerosis?

Each MS study answers this differently. In some, you need a diagnosis that has already been confirmed. In others, the assessment happens at screening. The study team will let you know which one applies.

Would I have to change the care I receive now?

Make no changes to your care by yourself. Certain MS studies let your current care carry on, while others do not permit that. This is something the study doctor reviews with you, and before you decide you can also discuss it with your own doctor.

Is there a cost to take part?

As a participant, you generally do not pay for study visits, study tests, or the study medication. Find out more about costs.

Ask about multiple sclerosis studies

After you send in a few details about your interest in MS studies, expect to hear from a coordinator. An inquiry leaves you under no obligation.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call